This article was originally published in The Gray Sheet
Acquires Carmel, New York-based GSI, Inc., manufacturer of "five different mattress models designed to convert the home care bed into a low air loss bed," according to a July 13 Invacare press release. Low air loss therapy products "are designed to move air through the surface on which the patient is lying in order to reduce heat and moisture buildup," preventing or aiding in the treatment of sores, burns or "other skin-related ailments." GSI has annual revenues of $4 mil. to $5 mil. and "should immediately contribute to Invacare's earnings." Terms of the deal were not disclosed. The acquisition follows on the heels of Invacare's purchase of Christchurch, New Zealand-based Dynamic Controls ("The Gray Sheet" July 5, p. 19)....
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.